Neil Frazer, a former researcher at Glaxo Wellcome, Erimos Pharmaceuticals and Shire Pharmaceuticals, is the new chief medical officer at Chimerix.

Chimerix is developing antiviral therapeutics that are delivered orally.

Frazer was CMO and chief operating officer at Erimos before joining Chimerix. He received his medical degree at the University of Edinburgh Medical School.

Chimerix, which recently moved to new headquarters in Durham, now has 15 full-time employees.